Parnaparin vs Aspirin in the Treatment of Retinal Vein Occlusion

NCT00732927 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

67

Enrollment

OTHER

Sponsor class

Stopped slow recruitment rate

Conditions

Retinal Vein Occlusion

Interventions

DRUG: parnaparin
DRUG: aspirin

Sponsor

Università degli Studi dell'Insubria

Collaborators

[object Object]